Shijiazhuang Yiling Pharmaceutical Co Ltd Tangible Net Worth Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd tangible net worth ratio. Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Tangible Net Worth Ratio of 90.0% as of June 2026. This metric is calculated by deducting intangible assets (CN¥1.09 Billion) from net assets (CN¥10.90 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Shijiazhuang Yiling Pharmaceutical Co Lt strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Tangible net worth ratio of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. This chart shows how Shijiazhuang Yiling Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at 90.0%, reflecting net assets of CN¥10.90 Billion with intangible assets of CN¥1.09 Billion CNY. See 002603 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Shijiazhuang Yiling Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2008–2025)
Shijiazhuang Yiling Pharmaceutical Co Ltd tangible net worth ratio by year from 2008 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 002603 market cap overview.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 90.5% | CN¥10.98 Billion | CN¥1.05 Billion | CN¥13.67 Billion | ▲ +0.9 pp |
| 2024 | 89.6% | CN¥10.20 Billion | CN¥1.07 Billion | CN¥13.32 Billion | ▼ -2.3 pp |
| 2023 | 91.9% | CN¥11.44 Billion | CN¥928.99 Million | CN¥16.98 Billion | ▼ -0.5 pp |
| 2022 | 92.4% | CN¥10.93 Billion | CN¥827.96 Million | CN¥16.34 Billion | ▲ +2.3 pp |
| 2021 | 90.1% | CN¥9.07 Billion | CN¥897.95 Million | CN¥12.90 Billion | ▼ -1.6 pp |
| 2020 | 91.7% | CN¥8.92 Billion | CN¥736.65 Million | CN¥11.51 Billion | ▲ +1.2 pp |
| 2019 | 90.5% | CN¥7.95 Billion | CN¥754.39 Million | CN¥9.07 Billion | ▼ -2.1 pp |
| 2018 | 92.6% | CN¥7.56 Billion | CN¥561.98 Million | CN¥8.56 Billion | ▲ +0.1 pp |
| 2017 | 92.4% | CN¥7.11 Billion | CN¥537.82 Million | CN¥7.89 Billion | ▲ +2.1 pp |
| 2016 | 90.3% | CN¥5.33 Billion | CN¥515.63 Million | CN¥6.26 Billion | ▼ 0.0 pp |
| 2015 | 90.3% | CN¥4.83 Billion | CN¥466.56 Million | CN¥5.71 Billion | ▼ -1.1 pp |
| 2014 | 91.4% | CN¥4.42 Billion | CN¥378.54 Million | CN¥5.09 Billion | ▼ -0.3 pp |
| 2013 | 91.7% | CN¥4.26 Billion | CN¥353.99 Million | CN¥4.66 Billion | ▲ +0.5 pp |
| 2012 | 91.1% | CN¥3.84 Billion | CN¥340.67 Million | CN¥4.17 Billion | ▼ -1.7 pp |
| 2011 | 92.9% | CN¥3.70 Billion | CN¥263.81 Million | CN¥4.23 Billion | ▲ +15.5 pp |
| 2010 | 77.4% | CN¥1.09 Billion | CN¥246.85 Million | CN¥1.77 Billion | ▼ -11.2 pp |
| 2009 | 88.5% | CN¥790.55 Million | CN¥90.58 Million | CN¥1.51 Billion | ▼ -4.8 pp |
| 2008 | 93.4% | CN¥484.03 Million | CN¥32.06 Million | CN¥831.91 Million | — |